Non-Surgical Chin Augmentation: Restylane® Lyft FDA Approval
Exploring the clinical data, facial balancing principles, and patient safety considerations behind the latest FDA approval for non-surgical chin enhancement.
On November 5, 2025, the U.S. Food and Drug Administration (FDA) approved Restylane® Lyft for non-surgical chin augmentation in adults with mild-to-moderate chin retrusion.
This announcement marks a significant development in the growing trend of non-surgical facial balancing, providing certified aesthetic providers with a trusted and effective tool to enhance the lower face.
This article offers a comprehensive overview for both practitioners and patients, covering the product’s history, the principles of facial harmony, the clinical data behind the approval, and crucial safety considerations.
In this article, you'll learn:
- The history of Restylane® Lyft and its evolution from facial wrinkles to comprehensive lower face contouring
- Why the chin is critical for facial balance and what practitioners should assess when evaluating the lower face
- Clinical trial results showing 89% patient satisfaction at 12 months and the importance of the firmer gel formulation
- How to identify qualified providers for this advanced treatment and why lower face injections require specialized expertise
Table of Contents
A Brief History: The Evolution of the Restylane® Portfolio
Restylane® has long been a cornerstone of the aesthetic industry. It was the first hyaluronic acid (HA) filler to receive FDA approval in the United States back in 2003, pioneering the non-surgical approach to facial rejuvenation.
Restylane® Lyft, specifically, has a notable history of expanding its indications, demonstrating its versatility and trusted safety profile:
- 2015: First approved for cheek augmentation and correction of midface contour deficiencies.
- 2018: Became the first and only HA filler approved for restoring volume to the back of the hands.
- 2025: Now the only HA filler in the U.S. with indications for the midface, facial folds, hands, and chin.
This legacy is built on more than 25 years of global use and over 77 million treatments worldwide, establishing a robust foundation of safety and efficacy.
The Art of Facial Balancing: Why the Chin is Crucial
Facial balancing is the art of creating harmony and proportion between different facial features, with the chin playing a significant role in helping to achieve this balance. A well-defined chin anchors the lower face, improves the profile, and creates a seamless transition to the jawline.
When assessing the lower face, certified aesthetic providers should consider several factors:
- Profile View: Evaluate the relationship between the lips and the most projected point of the chin to ensure a balanced and natural-looking profile.
- Frontal View: Consider the chin’s width and shape relative to the jawline and overall facial structure.
- Dynamic Expression: Observe how the chin and surrounding tissues move with facial expressions to ensure results appear natural both at rest and in motion.
- Holistic Approach: Treat the lower face as an integrated unit, considering how enhancing the chin will complement the jawline and perioral area.
The Clinical Deep Dive: What the Data and Science Say
The Importance of a Firmer Gel
Restylane® Lyft is uniquely suited for structural enhancement due to its formulation. It uses Galderma’s proprietary NASHA® technology, which results in a firmer gel with a high G-prime.
For chin augmentation, this is critical. The high G-prime provides the necessary structural support and lift to project the chin forward, holding its shape in a way that can mimic the underlying bone structure.
Impressive Patient Satisfaction
The clinical trial data supporting the FDA approval highlights exceptional patient satisfaction and durable results.
Even a full year after treatment, 89% of patients still reported visible aesthetic benefits. Furthermore, 86.3% of patients expressed high satisfaction, agreeing that the results looked natural and successfully improved their lower face appearance.
Crucially, these outcomes were achieved with a strong safety profile, with no serious or unexpected adverse events reported during the study.
Foundational Knowledge: Fillers vs. Neurotoxins
- Dermal Fillers (like Restylane®): These are gels used to add volume, fill lines, and restore structure. They address volume loss and static wrinkles (wrinkles present at rest).
- Botulinum Toxins (like Botox® or Dysport®): These are neuromodulators that relax muscles to prevent the formation of dynamic wrinkles (wrinkles caused by expression, like crow’s feet).
A simple way to remember it is that fillers “fill and plump,” while neurotoxins “relax and smooth.”
Patient Safety: The Critical Importance of Provider Expertise
An Advanced Treatment
It cannot be overstated that lower face and chin injections are advanced aesthetic procedures. They demand a profound understanding of complex facial anatomy, including the precise location of nerves and critical blood vessels, to be performed safely.
For Established Aesthetic Practices:
Finding a Qualified Provider
Patients should research their cosmetic injector thoroughly. It is essential to choose a qualified and certified medical professional, such as a board-certified dermatologist, plastic surgeon, or a certified physician, nurse practitioner or physician assistant with extensive, specialized training in aesthetic injections.
Always ask about a provider’s specific experience with lower face contouring and request to see before-and-after photos of their actual patients.
Conclusion
The FDA approval of Restylane® Lyft for chin enhancement provides a reliable and effective tool for a growing patient demand. Backed by robust clinical data showing high patient satisfaction and a long-standing global safety record, it is well-positioned to meet the needs of those seeking non-surgical facial balancing.
However, the success and safety of any advanced treatment ultimately depend on the skill of the injector. Patients are urged to prioritize finding a highly trained and experienced provider to ensure they achieve the beautiful, natural-looking results they desire.
Aesthetic Medicine Certification & Excellence
Earn your certification and designation as trusted Certified Aesthetic Provider™ (CAP) and show your patients your commitment to the highest standards in training and care.
From Botox® and fillers to PRP, PDO threads, chemical peels and more, this is your one stop shop for CME-accredited training from an internationally-recognized association with 20 years of aesthetic medicine excellence.
Sources:
- Galderma. (2025, November 5). Galderma receives U.S. FDA approval for Restylane® Lyft™ for the enhancement of the chin profile. https://www.galderma.com/news/galderma-receives-us-fda-approval-restylane-lyft
- Grasso, G. M., & Bagha, S. (2025, November 11 ). FDA approves Restylane Lyft to treat receding chin. Healio. https://www.galderma.com/news/galderma-receives-us-fda-approval-restylane-lyft
- Practical Dermatology. (2025, November 5 ). FDA Approves Restylane Lyft for Chin Augmentation in Adults. https://practicaldermatology.com/news/fda-approves-restylane-lyft-for-chin-augmentation-in-adults/2484326/
- Bido, T. (2025, November 5 ). Restylane Lyft Gets FDA Approval for Chin Enhancement. NewBeauty. https://www.newbeauty.com/restylane-lyft-gets-fda-approval-for-chin-enhancement/
- Galderma. (2021, September 30 ). RESTYLANE® celebrates 25 years of natural-looking results with its signature line of hyaluronic acid fillers. https://www.galderma.com/news/restylaner-celebrates-25-years-natural-looking-results-its-signature-line-hyaluronic-acid
- Galderma. (2018, May 22 ). FDA Approval of Restylane® Lyft for Hands. https://www.galderma.com/news/fda-approval-restylaner-lyft-hands
- FirstWord Pharma. (2015, July 2 ). Galderma Receives FDA Approval to Market Restylane Lyft with Lidocaine to Correct Age Related Volume Loss in the Cheek Area. https://firstwordpharma.com/story/2819385
